AMPYRA was approved on January 22.

Acorda has also put a program set up to help individuals with private insurance manage their co-payment costs, where allowed by law. Healthcare professionals and people with MS can get in touch with AMPYRA Patient Support Services at 888-881-1918 from 8:00 a.m. To 8:00 p.m. Eastern Time to learn more about AMPYRA, and to learn more about the patient assistance and co-pay mitigation programs. SOURCE Acorda Therapeutics.. AMPYRA for MS: Acorda Therapeutics announces wholesale prices and patient assistance program Acorda Therapeutics, Inc. AMPYRA was approved on January 22, 2013 by the U.S. Food and Drug Administration as a treatment to improve walking in individuals with multiple sclerosis .

The principal outcomes of the analysis were in-hospital mortality and door-to-balloon time. Multivariable model analyses were performed with in-medical center mortality as the dependent variable in a logistic-regression model and door-to-balloon period as the dependent variable in a linear-regression model. The independent variables that were regarded in the models were those for individuals with ST-segment elevation myocardial infarction in the NCDR model for in-hospital mortality.13 The analyses were repeated in high-risk subgroups of individuals: those more than 75 years, those presenting with cardiogenic shock, and the ones with an anterior myocardial infarction.The principal outcomes of the analysis were in-hospital mortality and door-to-balloon time. Multivariable model analyses were performed with in-medical center mortality as the dependent variable in a logistic-regression model and door-to-balloon period as the dependent variable in a linear-regression model. The independent variables that were regarded in the models were those for individuals with ST-segment elevation myocardial infarction in the NCDR model for in-hospital mortality.13 The analyses were repeated in high-risk subgroups of individuals: those more than 75 years, those presenting with cardiogenic shock, and the ones with an anterior myocardial infarction.